Media-OutReach Newswire Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets
Politics & Law Fulbright University Việt Nam's activities are welcomed: Foreign ministry's spokeswoman